Aesthetic Laser - Medical Devices Pipeline Assessment, 2017

  • ID: 4296585
  • Report
  • 94 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Cutera Inc
  • Erchonia Corp
  • Eternity Healthcare Inc.
  • Medifirst Solutions Inc
  • Medixsysteme
  • PS Advanced Engineering
  • MORE
Aesthetic Laser - Medical Devices Pipeline Assessment, 2017

Summary

The author's Medical Devices sector report, “Aesthetic Laser - Medical Devices Pipeline Assessment, 2017" provides an overview of Aesthetic Laser currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Aesthetic Laser pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Aesthetic Laser under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Aesthetic Laser and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry

Reasons to buy

The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Aesthetic Laser under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Cutera Inc
  • Erchonia Corp
  • Eternity Healthcare Inc.
  • Medifirst Solutions Inc
  • Medixsysteme
  • PS Advanced Engineering
  • MORE
1 Table of Contents
2 Introduction
2.1 Aesthetic Laser Overview
3 Products under Development
3.1 Aesthetic Laser - Pipeline Products by Stage of Development
3.2 Aesthetic Laser - Pipeline Products by Territory
3.3 Aesthetic Laser - Pipeline Products by Regulatory Path
3.4 Aesthetic Laser - Pipeline Products by Estimated Approval Date
3.5 Aesthetic Laser - Ongoing Clinical Trials
4 Aesthetic Laser - Pipeline Products under Development by Companies
4.1 Aesthetic Laser Companies - Pipeline Products by Stage of Development
4.2 Aesthetic Laser - Pipeline Products by Stage of Development
5 Aesthetic Laser Companies and Product Overview
5.1 Cutera Inc Company Overview
5.1.1 Cutera Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Erchonia Corp Company Overview
5.2.1 Erchonia Corp Pipeline Products & Ongoing Clinical Trials Overview
5.3 Eternity Healthcare Inc. Company Overview
5.3.1 Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.4 Medifirst Solutions Inc Company Overview
5.4.1 Medifirst Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
5.5 Medixsysteme Company Overview
5.5.1 Medixsysteme Pipeline Products & Ongoing Clinical Trials Overview
5.6 PS Advanced Engineering Company Overview
5.6.1 PS Advanced Engineering Pipeline Products & Ongoing Clinical Trials Overview
5.7 Sienna Biopharmaceuticals Inc Company Overview
5.7.1 Sienna Biopharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Sybaritic Inc Company Overview
5.8.1 Sybaritic Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Aesthetic Laser- Recent Developments
6.1 May 09, 2017: Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range
6.2 May 05, 2017: Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership
6.3 May 04, 2017: Olympus Extends Portfolio of EndoTherapy Solutions at DDW
6.4 May 01, 2017: Cutera Reports First Quarter 2017 Financial Performance
6.5 Apr 27, 2017: Zimmer Biomet Reports First Quarter 2017 Financial Results
6.6 Apr 20, 2017: Cutera Announces Preliminary Financial Results for First Quarter of 2017 and Planned Management Change
6.7 Apr 11, 2017: Low-Level Light Therapy Accelerates Hair Growth in Chemotherapy Patients
6.8 Apr 10, 2017: Medifirst Solutions Provides Update on International Sales
6.9 Mar 28, 2017: Synergy MedSales Introduces Newly FDA-Approved Forma-TK Lasers
6.10 Mar 01, 2017: Syneron Candela Unveils PicoWay at the 2017 American Academy of Dermatology (AAD) Annual Meeting
6.11 Feb 28, 2017: Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance
6.12 Feb 15, 2017: Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million
6.13 Feb 13, 2017: Cutera Reports Fourth Quarter and Full-Year 2016 Record Revenue and Financial Results
6.14 Feb 07, 2017: Cynosure Achieves Record Quarterly Revenue of $122.1 Million in the Fourth Quarter of 2016, Up 19 Percent Year-over-Year
6.15 Jan 31, 2017: Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
6.16 Jan 31, 2017: Zimmer Biomet Reports Fourth Quarter and Full-Year 2016 Financial Results
6.17 Jan 17, 2017: Medifirst Solutions to Present Its Time Machine Laser in Morocco and Dubai
6.18 Jan 17, 2017: Zimmer Biomet Announces Americas Leadership Transition
6.19 Jan 12, 2017: Zimmer Biomet Announces Resolution with DOJ and SEC Regarding Previously Disclosed Legacy Biomet FCPA Matters
6.20 Jan 10, 2017: Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results
6.21 Jan 09, 2017: Cutera Names James A. Reinstein as its Next President and CEO
6.22 Jan 09, 2017: Cutera Announces Record Revenue and Preliminary Financial Results for Fourth Quarter and Full Year 2016
6.23 Jan 04, 2017: Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors
6.24 Dec 14, 2016: Zimmer Biomet Update on Product Supply Matters and Responsive Statement on Recently Completed FDA Inspection
6.25 Dec 12, 2016: Valeant Appoints William D. Humphries As EVP, Dermatology
6.26 Dec 06, 2016: CUTERA Launches New PICO Genesis Treatment With enlighten
6.27 Nov 29, 2016: Cynosure Receives CFDA Clearance to Market the Icon Aesthetic System in China
6.28 Nov 22, 2016: Medifirst Solutions Appoints Bill White to Its Advisory Board
6.29 Nov 22, 2016: Medifirst Solutions appoints new advisory board member
6.30 Nov 21, 2016: Medifirst Solutions Announces Update on International Sales
6.31 Nov 17, 2016: Former Valeant Executive And Former Philidor Ceo Charged In Manhattan Federal Court For Illegal Fraud And Kickback Scheme
6.32 Nov 15, 2016: Cynosure Health Welcomes Three New Board Members
6.33 Nov 15, 2016: Quanta Aesthetic Lasers names CEO
6.34 Nov 09, 2016: Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million
6.35 Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results
6.36 Nov 07, 2016: Cutera Reports Record Third Quarter 2016 Results
6.37 Nov 03, 2016: Medifirst Solutions Announces Update Regarding International Sales and Operations
6.38 Nov 03, 2016: Cutera Elects J. Daniel Plants as Chairman of the Board
6.39 Nov 01, 2016: Cynosure Promotes Doug Delaney to Chief Commercial Officer
6.40 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results
6.41 Oct 25, 2016: Cynosure Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent from Prior Year to $106.4 Million
6.42 Oct 17, 2016: Medifirst Solutions Announces Update Regarding Sales and Operations
6.43 Oct 17, 2016: Syneron Medical Strengthens Senior Management Team
6.44 Oct 17, 2016: Syneron Medical Announces Preliminary Third Quarter 2016 Revenue
6.45 Oct 13, 2016: Aerolase Hires Prominent Laser Sales Executive as VP Sales to Accelerate Expansion
6.46 Oct 11, 2016: Cutera Announces Preliminary Record Third Quarter 2016 Revenue
6.47 Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer
6.48 Sep 13, 2016: Medifirst Solutions Announces Shareholder Update
6.49 Sep 13, 2016: Cynosure to Name Stephen J. Webber as New Chief Financial Officer
6.50 Aug 30, 2016: Apira Science’s iGrow Becomes First Wearable Laser Device to be Cleared by ANVISA in Brazil
6.51 Aug 30, 2016: Brazil Approves Apira's iGrow Wearable Laser Device
6.52 Aug 25, 2016: Medifirst Solutions Announces Engagement of International Monetary
6.53 Aug 22, 2016: Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer
6.54 Aug 18, 2016: Cutera Announces Management Changes
6.55 Aug 10, 2016: Valeant Pharmaceuticals Comments On SDNY Investigation
6.56 Aug 09, 2016: Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results
6.57 Aug 08, 2016: Valeant Pharmaceuticals Announces Changes To Executive Management Team
6.58 Aug 04, 2016: Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09
6.59 Aug 01, 2016: Cutera Reports Second Quarter 2016 Results
6.60 Jul 28, 2016: Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors
6.61 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results
6.62 Jul 26, 2016: Cynosure Receives Approval to Market SculpSure in South Korea
6.63 Jul 26, 2016: Cynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016
6.64 Jul 26, 2016: Medifirst Solutions to Update Shareholders on Corporate and Sales Strategy
6.65 Jul 25, 2016: Syneron Candela's PicoWay Picosecond Laser Receives U.S. FDA Clearance for Ultra-Short 785nm Wavelength
6.66 Jul 18, 2016: Medifirst Solutions Sets Pricing for Its Flagship Product
6.67 Jul 15, 2016: Medifirst Solutions Is Granted 510(k) FDA Clearance
6.68 Jul 13, 2016: Cynosure Receives Health Canada Authorization to Market SculpSure
6.69 Jul 05, 2016: Nail Fungus Sufferers Find Relief in New Laser Treatment
6.70 Jun 29, 2016: Medifirst Solutions Updates Shareholders on its FDA 510(K) Submission
6.71 Jun 23, 2016: Medifirst Solutions 510(k) Submission Has Been Accepted By The FDA
6.72 Jun 17, 2016: Valeant Pharmaceuticals Announces Significant Investments In Canadian Operations
6.73 Jun 16, 2016: Medifirst Solutions Announces Successful Completion of Testing for the Time Machine Laser Series
6.74 Jun 15, 2016: Valeant Pharmaceuticals Appoints Thomas W. Ross, Sr. Lead Independent Director
6.75 Jun 07, 2016: Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results
6.76 May 26, 2016: Valeant Pharmaceuticals Names Sam Eldessouky Senior Vice President And Corporate Controller
6.77 May 25, 2016: Cynosure Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer
6.78 May 24, 2016: Cynosure Receives FDA Clearance to Market New PicoSure Energy Delivery System for Tattoos and Pigmented Lesions
7 Appendix
7.1 Methodology

List of Tables
Table 1: Aesthetic Laser - Pipeline Products by Stage of Development
Table 2: Aesthetic Laser - Pipeline Products by Territory
Table 3: Aesthetic Laser - Pipeline Products by Regulatory Path
Table 4: Aesthetic Laser - Pipeline Products by Estimated Approval Date
Table 5: Aesthetic Laser - Ongoing Clinical Trials
Table 6: Aesthetic Laser Companies - Pipeline Products by Stage of Development
Table 7: Aesthetic Laser - Pipeline Products by Stage of Development
Table 8: Cutera Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: enlighten 670nm Laser - Skin Rejuvenation - Product Status
Table 10: enlighten 670nm Laser - Skin Rejuvenation - Product Description
Table 11: enlighten 670nm Laser - Tattoo Removal - Product Status
Table 12: enlighten 670nm Laser - Tattoo Removal - Product Description
Table 13: Cutera Inc - Ongoing Clinical Trials Overview
Table 14: enlighten 670nm Laser - Skin Rejuvenation - Study of a Novel Laser for Skin Rejuvenation
Table 15: enlighten 670nm Laser - Tattoo Removal - An Open Label, Split-tattoo Study Comparing the Safety and Efficacy of the 670nm Picosecond Laser Versus the 755 nm Picosecond Laser for Tattoo Removal
Table 16: Erchonia Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Low Level Laser - Hair Restoration - Product Status
Table 18: Low Level Laser - Hair Restoration - Product Description
Table 19: Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Hand-held Laser Hair Removal Device - Product Status
Table 21: Hand-held Laser Hair Removal Device - Product Description
Table 22: Medifirst Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Green Laser - 532 nm - Product Status
Table 24: Green Laser - 532 nm - Product Description
Table 25: Medixsysteme Pipeline Products & Ongoing Clinical Trials Overview
Table 26: SpaShape - Product Status
Table 27: SpaShape - Product Description
Table 28: Ultracontour - U.Lift - Product Status
Table 29: Ultracontour - U.Lift - Product Description
Table 30: PS Advanced Engineering Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Panelized Anti Wrinkle Platform - Product Status
Table 32: Panelized Anti Wrinkle Platform - Product Description
Table 33: Sienna Biopharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Silver Plasmonic Therapy (SPT) Device - Light Hair Removal - Product Status
Table 35: Silver Plasmonic Therapy (SPT) Device - Light Hair Removal - Product Description
Table 36: Sybaritic Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: SkinClear SRVH - Product Status
Table 38: SkinClear SRVH - Product Description
Table 39: Glossary

List of Figures
Figure 1: Aesthetic Laser - Pipeline Products by Stage of Development
Figure 2: Aesthetic Laser - Pipeline Products by Territory
Figure 3: Aesthetic Laser - Pipeline Products by Regulatory Path
Figure 4: Aesthetic Laser - Pipeline Products by Estimated Approval Date
Figure 5: Aesthetic Laser - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Cutera Inc
  • Erchonia Corp
  • Eternity Healthcare Inc.
  • Medifirst Solutions Inc
  • Medixsysteme
  • PS Advanced Engineering
  • Sienna Biopharmaceuticals Inc
  • Sybaritic Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll